Crinetics Pharmaceuticals Announces October 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
October 10, 2025 16:41 ET Â | Source: Crinetics Pharmaceuticals, Inc. SAN DIEGO,…
BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
October 03, 2025 16:01 ET Â | Source: BridgeBio Pharma, Inc. PALO ALTO,…
Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
October 03, 2025 16:01 ET Â | Source: Intellia Therapeutics, Inc. CAMBRIDGE, Mass.,…
Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
October 01, 2025 17:20 ET Â | Source: ZENTALIS PHARMACEUTICALS SAN DIEGO, Oct.…
Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
September 12, 2025 16:30 ET Â | Source: Fulcrum Therapeutics, Inc. CAMBRIDGE, Mass.,…
Rackspace Technology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
September 05, 2025 18:00 ET Â | Source: Rackspace US, Inc. SAN ANTONIO,…
Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
August 01, 2025 16:55 ET Â | Source: Xenon Pharmaceuticals Inc. VANCOUVER, British…
Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
August 01, 2025 17:06 ET Â | Source: Taysha Gene Therapies, Inc. DALLAS,…
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
July 18, 2025 16:30 ET Â | Source: Ultragenyx Pharmaceutical Inc. NOVATO, Calif.,…
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
July 18, 2025 17:15 ET Â | Source: Iovance Biotherapeutics, Inc. SAN CARLOS,…